Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease

Fig. 2

Correlation of FVC at baseline between home handheld spirometry and site spirometry in a STARLINER, b STARMAP, c the pirfenidone in uILD study (placebo group) and d the pirfenidone in uILD study (pirfenidone group). For home handheld spirometry, baseline was calculated as the average of assessments collected during the first 7 days. FVC forced vital capacity, L litres, uILD unclassifiable interstitial lung disease

Back to article page